GlassScriptPhysician profile
Michele W Maranto
NPI 1174590731
$3,183.61
in general payments reported to CMS, 2019-2025
33 companies · $204 in 2025
The $204 reported for 2025 was more than what a typical Nurse Practitioner provider received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $382 · 2022: $1,260 · 2023: $1,047 · 2024: $291 · 2025: $204.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,541.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,541.23 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $821.98 | 2021-2025 | |
| Glaxosmithkline, LLC. | $526.92 | 2022-2024 | Trelegy Ellipta, Shingrix, Arexvy |
| Lilly USA, LLC | $243.90 | 2021-2025 | Mounjaro, Jardiance, Emgality |
| Astrazeneca Pharmaceuticals LP | $194.67 | 2021-2023 | Andexxa, Fasenra |
| Takeda Pharmaceuticals U.S.A., INC. | $141.46 | 2021-2023 | Trintellix |
| Astellas Pharma US INC | $134.11 | 2021-2025 | Veozah, Myrbetriq |
| Novo Nordisk INC | $111.26 | 2021-2025 | Rybelsus, Ozempic |
| Biohaven Pharmaceutical Holding Company LTD. | $103.58 | 2022 | |
| Sanofi Pasteur INC. | $89.40 | 2021-2023 | |
| Exact Sciences Corporation | $74.69 | 2023-2025 | Cologuard Collection Kit |
| Merck Sharp & Dohme LLC | $74.26 | 2021-2022 | |
| Amgen INC. | $67.23 | 2021-2024 | Prolia, Evenity |
| Boehringer Ingelheim Pharmaceuticals, INC. | $64.74 | 2021-2022 | |
| Pfizer INC. | $57.96 | 2022-2023 | |
| Novartis Pharmaceuticals Corporation | $56.42 | 2021-2023 |
Show all 33 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Shield Therapeutics INC | $51.20 | 2025 | |
| Genentech USA, INC. | $45.95 | 2021-2022 | |
| Dynavax Technologies Corporation | $45.19 | 2021-2022 | |
| Halozyme INC | $35.75 | 2023 | |
| Idorsia Pharmaceuticals US INC | $31.84 | 2022 | |
| Medtronic, INC. | $25.49 | 2024 | Intellis Adaptivestim |
| Althera Pharmaceuticals LLC | $22.47 | 2022 | |
| Hologic Sales and Service, LLC | $22.14 | 2024 | Aptima, Thinprep 2000 Processor |
| Therapeuticsmd, INC. | $18.37 | 2021 | |
| Janssen Pharmaceuticals, INC | $17.22 | 2021 | |
| Inspire Medical Systems, INC. | $16.16 | 2025 | Inspire |
| Otsuka America Pharmaceutical, INC. | $15.50 | 2022 | |
| Antares Pharma, INC. | $15.45 | 2021 | |
| Jazz Pharmaceuticals INC. | $14.73 | 2022 | |
| Esperion Therapeutics, INC. | $13.67 | 2024 | Nexletol |
| E.R. Squibb & Sons, L.L.C. | $13.46 | 2023 | Eliquis |
| Upsher-Smith Laboratories LLC | $13.19 | 2022 | |
| Inogen, INC. | $3.25 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michele Maranto listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.